M

Mural Oncology PLC
NASDAQ:MURA

Watchlist Manager
Mural Oncology PLC
NASDAQ:MURA
Watchlist
Price: 2.08 USD -0.95% Market Closed
Market Cap: 36m USD

Intrinsic Value

The intrinsic value of one MURA stock under the Base Case scenario is 8.34 USD. Compared to the current market price of 2.08 USD, Mural Oncology PLC is Undervalued by 75%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MURA Intrinsic Value
8.34 USD
Undervaluation 75%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Mural Oncology PLC

What is Valuation History?
Ask AI Assistant
What other research platforms think about MURA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MURA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Mural Oncology PLC.

Explain Valuation
Compare MURA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MURA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mural Oncology PLC

Current Assets 81.6m
Cash & Short-Term Investments 77.1m
Other Current Assets 4.5m
Non-Current Assets 6m
PP&E 6m
Current Liabilities 28.4m
Accounts Payable 3.1m
Accrued Liabilities 25.2m
Other Current Liabilities 45k
Non-Current Liabilities 354k
Other Non-Current Liabilities 354k
Efficiency

Free Cash Flow Analysis
Mural Oncology PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mural Oncology PLC

Revenue
0 USD
Operating Expenses
-135.7m USD
Operating Income
-135.7m USD
Other Expenses
-11.5m USD
Net Income
-147.2m USD
Fundamental Scores

MURA Profitability Score
Profitability Due Diligence

Mural Oncology PLC's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
38/100
Profitability
Score

Mural Oncology PLC's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

MURA Solvency Score
Solvency Due Diligence

Mural Oncology PLC's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
56/100
Solvency
Score

Mural Oncology PLC's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MURA Price Targets Summary
Mural Oncology PLC

There are no price targets for MURA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Mural Oncology PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for MURA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MURA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MURA stock?

The intrinsic value of one MURA stock under the Base Case scenario is 8.34 USD.

Is MURA stock undervalued or overvalued?

Compared to the current market price of 2.08 USD, Mural Oncology PLC is Undervalued by 75%.

Back to Top